Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer

Summary

RATIONALE: Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well pazopanib hydrochloride works in treating patients with stage IV kidney cancer.

Timeline

Start

2010-12-08

Primary completion

2013-10-17

Completion

2013-12-31

Drugs

Indications